CXCL5

From WikiMD's Wellness Encyclopedia

CXCL5 is a small cytokine belonging to the CXC chemokine family that is also known as epithelial-derived neutrophil-activating peptide 78 (ENA-78). It is produced following stimulation of cells such as epithelial cells, platelets, and monocytes with the inflammatory cytokines interleukin-1 or tumor necrosis factor-alpha. Expression of this gene is also induced by epidermal growth factor.

Function[edit | edit source]

CXCL5 is a chemotactic agent for neutrophil granulocytes. It attracts these cells by interacting with the cell surface chemokine receptor CXCR2. Its gene is located in a cluster of other chemokines on chromosome 4q13.3 in humans.

Clinical significance[edit | edit source]

CXCL5 has been implicated in various inflammatory and cancer-related conditions. It is associated with inflammatory diseases such as rheumatoid arthritis, lung fibrosis, and atherosclerosis. In cancer, it has been shown to promote angiogenesis, tumor growth, and metastasis.

See also[edit | edit source]

References[edit | edit source]


External links[edit | edit source]



CXCL5 Resources

Contributors: Prab R. Tumpati, MD